Financials data is unavailable for this security.
View more
Year on year Shanghai Haohai Biological Technology Co Ltd grew revenues 24.59% from 2.13bn to 2.65bn while net income improved 130.58% from 180.47m to 416.12m.
| Gross margin | 68.97% |
|---|---|
| Net profit margin | 14.61% |
| Operating margin | 18.43% |
| Return on assets | 5.60% |
|---|---|
| Return on equity | 7.56% |
| Return on investment | 6.60% |
More ▼
Cash flow in CNYView more
In 2023, Shanghai Haohai Biological Technology Co Ltd did not generate a significant amount of cash. However, the company earned 634.45m from its operations for a Cash Flow Margin of 23.91%. In addition the company used 376.65m on investing activities and also paid 257.73m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 24.07 |
|---|---|
| Tangible book value per share | 19.18 |
More ▼
Balance sheet in CNYView more
| Current ratio | 4.30 |
|---|---|
| Quick ratio | 3.71 |
| Total debt/total equity | 0.0798 |
|---|---|
| Total debt/total capital | 0.0697 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 150.00% and 134.62%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 0.64% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 60.44% |
| EPS growth(5 years) | -1.19 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 29.46 |
More ▼
